Data / Form D filings / EAGLE PHARMACEUTICALS, INC.
EAGLE PHARMACEUTICALS, INC.: Form D filings
EAGLE PHARMACEUTICALS, INC., a pharmaceuticals company in Woodcliff Lake, NJ, filed 2 Form D notices with the SEC between 2011 and 2016. The latest, on November 23, 2016, reports $2.7 million sold of a $50.7 million offering to 2 investors.
Find out what EAGLE PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 50 TICE BOULEVARD, SUITE 315, Woodcliff Lake, NJ, 07677
- Phone
- (201) 326-5300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 827871
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 23, 2016 | New notice | $50,740,728 | $2,740,728 | $48,000,000 | 2 | Nov 16, 2016 | sec.gov |
| Feb 18, 2011 | New notice | $18,522,295 | $12,348,194 | $6,174,101 | 18 | Feb 8, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David E. Riggs | Executive Officer | |
| Sander E. Flaum | Director | |
| Scott Tarriff | Executive Officer, Director | |
| Douglas L. Braunstein | Director | |
| Steven L. Krill | Executive Officer | |
| David E. Pernock | Director | |
| Michael E. Graves | Director | |
| Steven E. Ratoff | Director | |
| Robert L. Glenning | Director | |
| Adrian E. Hepner | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Nov 21, 2016 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what EAGLE PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.